Prion diseases

Seminars in Neurology

Volumn 33, Issue 4, 2013, Pages 348-356

  Takada, Leonel T ^a   Geschwind, Michael D ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Creutzfeldt Jakob disease; familial fatal insomnia; Gerstmann Str ussler Scheinker disease; prion diseases; rapidly progressive dementia

Indexed keywords

PRION PROTEIN;

AKINETIC MUTISM; ARTICLE; BRAIN ATROPHY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DISEASE DURATION; DIZZINESS; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FATAL FAMILIAL INSOMNIA; GENE MUTATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HEADACHE; HUMAN; INHERITANCE; INSOMNIA; INTESTINE EPITHELIUM; LYMPHOID TISSUE; MYOCLONUS; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASYMPATHETIC NERVE; PATHOPHYSIOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRION DISEASE; PRIORITY JOURNAL; SLEEP DISORDER; SOMATIC MUTATION; VISUAL DISORDER; WORLD HEALTH ORGANIZATION;

HUMANS; PRION DISEASES;

EID: 84887832085     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0033-1359314     Document Type: Article

References (97)

1. Prusiner S. B. Prions. Proc Natl Acad Sci U S A: 1998; 95 23 13363 13383 (Pubitemid 28525623)
2. Masters C. L. Creutzfeldt-Jakob disease: its origins. Alzheimer Dis Assoc Disord: 1989; 3 1-2 46 51
3. Masters C. L., Harris J. O., Gajdusek D. C., Gibbs C. J. Jr, Bernoulli C., Asher D. M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol: 1979; 5 2 177 188 (Pubitemid 9195818)
4. Ladogana A., Puopolo M., Croes E. A., et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology: 2005; 64 9 1586 1591 (Pubitemid 40617696)
5. Holman R. C., Belay E. D., Christensen K. Y., et al. Human prion diseases in the United States. PLoS ONE: 2010; 5 1 e8521
6. Brown P., Cathala F., Castaigne P., Gajdusek D. C. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol: 1986; 20 5 597 602 (Pubitemid 17181761)
7. Buganza M., Ferrari S., Cecchini M. E., Orrico D., Monaco S., Zanusso G. The oldest old Creutzfeldt-Jakob disease case. J Neurol Neurosurg Psychiatry: 2009; 80 10 1140 1142
8. Berman P. H., Davidson G. S., Becker L. E. Progressive neurological deterioration in a 14-year-old girl. Pediatr Neurosci: 1988; 14 1 42 49
9. Corato M., Cereda C., Cova E., Ferrarese C., Ceroni M. Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol: 2006; 21 4 211 215 (Pubitemid 46578450)
10. Kanaani J., Prusiner S. B., Diacovo J., Baekkeskov S., Legname G. Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem: 2005; 95 5 1373 1386 (Pubitemid 41779262)
11. Mallucci G. R., White M. D., Farmer M., et al. Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron: 2007; 53 3 325 335 (Pubitemid 46161264)
12. Colby D. W., Prusiner S. B. Prions. Cold Spring Harb Perspect Biol: 2011; 3 1 a006833
13. van der Kamp M. W., Daggett V. Pathogenic mutations in the hydrophobic core of the human prion protein can promote structural instability and misfolding. J Mol Biol: 2010; 404 4 732 748
14. Cobb N. J., Surewicz W. K. Prion diseases and their biochemical mechanisms. Biochemistry: 2009; 48 12 2574 2585
15. Parchi P., Castellani R., Capellari S., et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol: 1996; 39 6 767 778 (Pubitemid 26183813)
16. Hsiao K., Baker H. F., Crow T. J., et al. Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature: 1989; 338 6213 342 345 (Pubitemid 19082975)
17. Lloyd S. E., Mead S., Collinge J. Genetics of prion diseases. Curr Opin Genet Dev: 2013; 23 3 345 351
18. Kovács G. G., Puopolo M., Ladogana A., et al. EUROCJD Genetic prion disease: the EUROJCD experience. Hum Genet: 2005; 118 2 166 174 (Pubitemid 41672078)
19. Mastrianni J. A. The genetics of prion diseases. Genet Med: 2010; 12 4 187 195
20. Chapman J., Ben-Israel J., Goldhammer Y., Korczyn A. D. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology: 1994; 44 9 1683 1686 (Pubitemid 24286647)
21. Mitrová E., Belay G. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol: 2002; 46 1 31 39 (Pubitemid 34777676)
22. Parchi P., Giese A., Capellari S., et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol: 1999; 46 2 224 233 (Pubitemid 29382879)
23. Hohler A. D., Flynn F. G. Onset of Creutzfeldt-Jakob disease mimicking an acute cerebrovascular event. Neurology: 2006; 67 3 538 539 (Pubitemid 44214998)
24. Rabinovici G. D., Wang P. N., Levin J., et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology: 2006; 66 2 286 287 (Pubitemid 43970180)
25. Will R. G., Matthews W. B. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry: 1984; 47 2 134 140 (Pubitemid 14154718)
26. Maltête D., Guyant-Maréchal L., Mihout B., Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord: 2006; 12 2 65 71 (Pubitemid 43234305)
27. Edler J., Mollenhauer B., Heinemann U., et al. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Disord: 2009; 24 3 350 356
28. Espinosa P. S., Bensalem-Owen M. K., Fee D. B. Sporadic Creutzfeldt-Jakob disease presenting as nonconvulsive status epilepticus case report and review of the literature. Clin Neurol Neurosurg: 2010; 112 6 537 540
29. Kovács T., Arányi Z., Szirmai I., Lantos P. L. Creutzfeldt-Jakob disease with amyotrophy and demyelinating polyneuropathy. Arch Neurol: 2002; 59 11 1811 1814 (Pubitemid 35340493)
30. Paterson R. W., Torres-Chae C. C., Kuo A. L., et al. Differential diagnosis of jakob-creutzfeldt disease. Arch Neurol: 2012; 69 12 1578 1582
31. Kovacs G. G., Seguin J., Quadrio I., et al. Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol: 2011; 121 1 39 57
32. Esiri M. M., Gordon W. I., Collinge J., Patten J. S. Peripheral neuropathy in Creutzfeldt-Jakob disease. Neurology: 1997; 48 3 784 (Pubitemid 27120127)
33. Antoine J. C., Laplanche J. L., Mosnier J. F., Beaudry P., Chatelain J., Michel D. Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene. Neurology: 1996; 46 4 1123 1127 (Pubitemid 26139738)
34. Chapman J., Brown P., Goldfarb L. G., Arlazoroff A., Gajdusek D. C., Korczyn A. D. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry: 1993; 56 10 1109 1112 (Pubitemid 23304704)
35. Pocchiari M., Puopolo M., Croes E. A., et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain: 2004; 127 Pt 10 2348 2359 (Pubitemid 39382243)
36. WHO Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO Consultation Geneva, Switzerland, 9-11 February 1998. Geneva, Switzerland World Health Organization: 1998
37. Geschwind M. D., Josephs K. A., Parisi J. E., Keegan B. M. A 54-year-old man with slowness of movement and confusion. Neurology: 2007; 69 19 1881 1887 (Pubitemid 350071150)
38. Zerr I., Kallenberg K., Summers D. M., et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain: 2009; 132 Pt 10 2659 2668
39. Puoti G., Bizzi A., Forloni G., Safar J. G., Tagliavini F., Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol: 2012; 11 7 618 628
40. Parchi P., Capellari S., Chin S., et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology: 1999; 52 9 1757 1763 (Pubitemid 29260886)
41. Cali I., Castellani R., Alshekhlee A., et al. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain: 2009; 132 Pt 10 2643 2658
42. Parchi P., Strammiello R., Notari S., et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol: 2009; 118 5 659 671
43. Appleby B. S., Appleby K. K., Crain B. J., Onyike C. U., Wallin M. T., Rabins P. V. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol: 2009; 66 2 208 215
44. Gambetti P., Kong Q., Zou W., Parchi P., Chen S. G. Sporadic and familial CJD: classification and characterisation. Br Med Bull: 2003; 66 1 213 239 (Pubitemid 37173504)
45. Worrall B. B., Rowland L. P., Chin S. S., Mastrianni J. A. Amyotrophy in prion diseases. Arch Neurol: 2000; 57 1 33 38 (Pubitemid 30027612)
46. Jansen C., Head M. W., Rozemuller A. J., Ironside J. W. Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol: 2009; 35 3 272 282
47. Mizutani T., Okumura A., Oda M., Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry: 1981; 44 2 103 115 (Pubitemid 11137900)
48. Zou W. Q., Puoti G., Xiao X., et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol: 2010; 68 2 162 172
49. Vitali P., Maccagnano E., Caverzasi E., et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology: 2011; 76 20 1711 1719
50. Shiga Y., Miyazawa K., Sato S., et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology: 2004; 63 3 443 449 (Pubitemid 39031372)
51. Shiga Y., Miyazawa K., Sato S., et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology: 2004; 63 3 443 449 (Pubitemid 39031372)
52. Young G. S., Geschwind M. D., Fischbein N. J., et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol: 2005; 26 6 1551 1562 (Pubitemid 43733460)
53. Geschwind M. D., Potter C. A., Sattavat M., et al. Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Dis Assoc Disord: 2009; 23 1 82 87
54. Letourneau-Guillon L., Wada R., Kucharczyk W. Imaging of prion diseases. J Magn Reson Imaging: 2012; 35 5 998 1012
55. Carswell C., Thompson A., Lukic A., et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol: 2012; 12 1 153
56. Geschwind M. D., Kuryan C., Cattaruzza T., Vitali P., DeArmond S., Wong K. Brain MRI in sporadic Jakob-Creutzfeldt disease is often misread. Neurology: 2010; 74 02 A213
57. Muayqil T., Gronseth G., Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology: 2012; 79 14 1499 1506
58. Coulthart M. B., Jansen G. H., Olsen E., et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol: 2011; 11 133
59. van Harten A. C., Kester M. I., Visser P. J., et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med: 2011; 49 3 353 366
60. Sanchez-Juan P., Green A., Ladogana A., et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology: 2006; 67 4 637 643 (Pubitemid 44273611)
61. Deisenhammer F., Egg R., Giovannoni G., et al. EFSN EFNS guidelines on disease-specific CSF investigations. Eur J Neurol: 2009; 16 6 760 770
62. Geschwind M. D., Martindale J., Miller D., et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol: 2003; 60 6 813 816 (Pubitemid 36705966)
63. Stoeck K., Sanchez-Juan P., Gawinecka J., et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain: 2012; 135 Pt 10 3051 3061
64. Steinhoff B. J., Zerr I., Glatting M., Schulz-Schaeffer W., Poser S., Kretzschmar H. A. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol: 2004; 56 5 702 708 (Pubitemid 39540751)
65. Tschampa H. J., Neumann M., Zerr I., et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry: 2001; 71 1 33 39
66. Seipelt M., Zerr I., Nau R., et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry: 1999; 66 2 172 176 (Pubitemid 29103517)
67. Budka H. Neuropathology of prion diseases. Br Med Bull: 2003; 66 121 130 (Pubitemid 37173497)
68. Venneti S. Prion diseases. Clin Lab Med: 2010; 30 1 293 309
69. Capellari S., Strammiello R., Saverioni D., Kretzschmar H., Parchi P. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol: 2011; 121 1 21 37
70. Brown K., Mastrianni J. A. The prion diseases. J Geriatr Psychiatry Neurol: 2010; 23 4 277 298
71. Arata H., Takashima H., Hirano R., et al. Early clinical signs and imaging findings in Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu). Neurology: 2006; 66 11 1672 1678 (Pubitemid 43964621)
72. Goldfarb L. G., Petersen R. B., Tabaton M., et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science: 1992; 258 5083 806 808
73. Will R. G. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull: 2003; 66 255 265 (Pubitemid 37173506)
74. Collinge J., Whitfield J., McKintosh E., et al. Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet: 2006; 367 9528 2068 2074 (Pubitemid 43949290)
75. Brown P., Brandel J. P., Preece M., Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology: 2006; 67 3 389 393 (Pubitemid 44214958)
76. Brown P., Brandel J. P., Sato T., et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis: 2012; 18 6 901 907
77. World Health Organization WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies; Report of the WHO Consultation in Geneva 14-16 September 2005. Geneva, Switzerland Quality and Safety of Plasma Derivatives and Related Substances, Department of Medicines Policy and Standards, Health Technology and Pharmaceuticals Cluster, World Health Organization: 2006
78. Will R. G., Ironside J. W., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet: 1996; 347 9006 921 925 (Pubitemid 26102546)
79. Norrby E. Prions and protein-folding diseases. J Intern Med: 2011; 270 1 1 14
80. Kaski D., Mead S., Hyare H., et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet: 2009; 374 9707 2128
81. Heath C. A., Cooper S. A., Murray K., et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol: 2010; 67 6 761 770
82. Binelli S., Agazzi P., Giaccone G., et al. Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol: 2006; 59 2 423 427 (Pubitemid 43202504)
83. Collie D. A., Summers D. M., Sellar R. J., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol: 2003; 24 8 1560 1569 (Pubitemid 37151720)
84. Petzold G. C., Westner I., Bohner G., Einhäupl K. M., Kretzschmar H. A., Valdueza J. M. False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology: 2004; 62 7 1235 1236 (Pubitemid 38456536)
85. Fulbright R. K., Hoffmann C., Lee H., Pozamantir A., Chapman J., Prohovnik I. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol: 2008; 29 9 1638 1643
86. Will R. Variant Creutzfeldt-Jakob disease. Folia Neuropathol: 2004; 42 (Suppl A): 77 83
87. Llewelyn C. A., Hewitt P. E., Knight R. S., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet: 2004; 363 9407 417 421 (Pubitemid 38210057)
88. Dorsey K., Zou S., Schonberger L. B., et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion: 2009; 49 5 977 984
89. Ironside J. W. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol: 2012; 50 1 50 56
90. Hilton D. A., Ghani A. C., Conyers L., et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ: 2002; 325 7365 633 634
91. Hilton D. A., Ghani A. C., Conyers L., et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol: 2004; 203 3 733 739 (Pubitemid 38961558)
92. Paterson R. W., Takada L. T., Geschwind M. D. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract: 2012; 2 3 187 200
93. Kranitz F. J., Simpson D. M. Using non-pharmacological approaches for CJD patient and family support as provided by the CJD foundation and CJD insight. CNS Neurol Disord Drug Targets: 2009; 8 5 372 379
94. Chitravas N., Jung R. S., Kofskey D. M., et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol: 2011; 70 3 437 444
95. Atarashi R., Satoh K., Sano K., et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med: 2011; 17 2 175 178
96. Edgeworth J. A., Farmer M., Sicilia A., et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet: 2011; 377 9764 487 493
97. Geschwind M. D. Clinical trials for prion disease: difficult challenges, but hope for the future. Lancet Neurol: 2009; 8 4 304 306